Sema4 Holdings Corp. announced that James Coffin, Ph.D., the President, and Chief Operating Officer, will leave the company for personal reasons, effective February 1, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.28 USD | +13.15% | +28.98% | +892.00% |
06-05 | GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients | CI |
04-30 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+892.00% | 713M | |
-22.94% | 7.77B | |
+75.58% | 4.51B | |
-2.63% | 2.67B | |
+6.55% | 2.76B | |
-47.96% | 2.09B | |
-16.87% | 1.72B | |
-20.12% | 1.49B | |
+18.29% | 1.22B | |
-44.77% | 1.12B |
- Stock Market
- Equities
- WGS Stock
- News GeneDx Holdings Corp.
- James Coffin to Leave Sema4 Holdings Corp. as President, and Chief Operating Officer